PharmaShots Weekly Snapshot (November 24 - 29, 2018)
Published: 29 Nov, 2018 | Tags: Novartis, Gilenya, (fingolimod), Receives, EU, Approval, Relapsing-Remitting, Forms, Multiple Sclerosis (RRMS), 10 to <18 yrs, PARADIGMS study, P-III
Published: 29 Nov, 2018 | Tags: NTU Singapore, TTSH, Develops, AI based, Medical Device, Early, Detection, Congestive Heart Failure
Published: 29 Nov, 2018 | Tags: Vertex, Kalydeco, (ivacaftor), Receives, FDAs, Expanded, Label, Approval , Cystic Fibrosis (CF), Aged 12 to < 24 Months
Published: 29 Nov, 2018 | Tags: Astellas, Xospata, gilteritinib, Receives, FDA s, Approval, Treatment, Relapsed/Refactory Acute Myeloid Leukemia, (AML), Adults
Published: 28 Nov, 2018 | Tags: ElectroCore, GammaCore (nVNS), Receives, FDA, 510(k), Approval, Cluster Headache, Adults
Published: 28 Nov, 2018 | Tags: Q BioMed, Acquires,Rights, Metastron, GE Healthcare
- Mercks Delstrigo (doravirine / lamivudine / tenofovir disoproxil fumarate) & Pifeltro (doravirine) Receives EUs Approval for the Treatment of HIV-1 Infection